CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 9 enrolled
Drug / intervention
Medtronic implantable deep brain stimulation (DBS) systemdevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT00773604
NCT00773604N/ACompleted
CompareCT.gov

Subthalamic Nucleus (STN) Deep Brain Stimulation (DBS) in Patients With Dystonia

University of California, San Francisco·interventional·Posted Oct 16, 2008·Updated Feb 19, 2019

In Brief

A clinical study evaluating Medtronic implantable deep brain stimulation (DBS) system for Dystonia. Completed, enrolled 9 participants across 2 sites.

Detailed Summary

The purpose of this study is to evaluate the safety and effectiveness of deep brain stimulation (DBS) of the subthalamic nucleus (STN)for primary dystonia.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsDystonia
CountriesUnited States
Collaborators--

Timeline

N/ACompletedFinished
20082009201020112012201320142015201620172018201920202021202220232024202520262027
First PostedOct 16, 2008
Enrollment StartJun 1, 2008
Primary CompletionFeb 1, 2015
TodayJul 2, 2026
Enrollment to primary: 6.7 yearsPosted 17.7 years ago

Interventions

Medtronic implantable deep brain stimulation (DBS) systemdevice

surgical placement of deep brain stimulation system for treatment of dystonia